Researcher.Life Logo

Neuro-Oncology Advances : Impact Factor & More

eISSN: 2632-2498
JournalOpen Access

Key Metrics

Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Neuro-Oncology Advances

Neuro-Oncology Advances Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Oxford University Press
Language English
Article Processing ChargesGBP 1500 | USD 2206
Publication Time12
Editorial Review ProcessPeer review
General Details
LanguageEnglish
Society/Institute/SponsorSociety for NeuroOncology
Website URLVisit website
Publication Details
Publication Time 12
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessPeer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Neuro-Oncology Advances ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Neuro-Oncology Advances

Time matters: the prognostic impact of diagnostic delay on survival in primary central nervous system lymphoma—a single-center, retrospective real-world study
  • 27 Oct 2025
  • Neuro-Oncology Advances
Unsupervised Learning of Metabolic Fingerprints from 3D MRSI Enables Glioma Subtype Classification
  • 23 Oct 2025
  • Neuro-Oncology Advances
LCLAT1 regulates cardiolipin composition, mitochondrial phenotype, Lin28A and oncogenic signaling networks in ETMR
  • 21 Oct 2025
  • Neuro-Oncology Advances
<i>Gliomap-GAN</i>: A conditional Generative Adversarial Network to visualize glioblastoma’s cell density from contrast-enhanced magnetic resonance imaging
  • 21 Oct 2025
  • Neuro-Oncology Advances
Breaking down glioma primary cilia disassembly
  • 10 Oct 2025
  • Neuro-Oncology Advances
T-cell receptor sequencing for detection of Epstein-Barr and Cytomegalovirus-specific immune responses in glioma patients: An exploratory study
  • 9 Oct 2025
  • Neuro-Oncology Advances
Time matters: the prognostic impact of diagnostic delay on survival in primary central nervous system lymphoma—a single-center, retrospective real-world study
  • 27 Oct 2025
  • Neuro-Oncology Advances
Unsupervised Learning of Metabolic Fingerprints from 3D MRSI Enables Glioma Subtype Classification
  • 23 Oct 2025
  • Neuro-Oncology Advances
LCLAT1 regulates cardiolipin composition, mitochondrial phenotype, Lin28A and oncogenic signaling networks in ETMR
  • 21 Oct 2025
  • Neuro-Oncology Advances
<i>Gliomap-GAN</i>: A conditional Generative Adversarial Network to visualize glioblastoma’s cell density from contrast-enhanced magnetic resonance imaging
  • 21 Oct 2025
  • Neuro-Oncology Advances
Breaking down glioma primary cilia disassembly
  • 10 Oct 2025
  • Neuro-Oncology Advances
T-cell receptor sequencing for detection of Epstein-Barr and Cytomegalovirus-specific immune responses in glioma patients: An exploratory study
  • 9 Oct 2025
  • Neuro-Oncology Advances

FAQs on Neuro-Oncology Advances